Ascites
Information
- Disease name
- Ascites
- Disease ID
- Description
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
| Genes | Mutation | Description | Source | Links |
|---|
| NCT ID | Status | Phase | Summary | Start date | Completion date |
|---|---|---|---|---|---|
| NCT04315571 | Active, not recruiting | N/A | Comparing Ascites Relief In Two Standard Treatments: Large Volume Paracentesis Vs. Early Tips Using Viatorr Controlled Expansion Stents | March 24, 2020 | January 1, 2026 |
| NCT03973866 | Active, not recruiting | N/A | Alfapump® System in the Treatment of Refractory or Recurrent Ascites (POSEIDON Study) | September 16, 2019 | June 30, 2024 |
| NCT00108355 | Completed | Phase 4 | Vasoconstrictors as Alternatives to Albumin After Large-Volume Paracentesis (LVP) in Cirrhosis | December 2003 | August 2012 |
| NCT00115947 | Completed | Phase 2/Phase 3 | Renal and Cardiovascular Effects of Terlipressin in Patients With Cirrhosis and Ascites | December 2004 | January 2006 |
| NCT00327444 | Completed | Phase 2/Phase 3 | Study of the Effect of Intravenous AVE0005 (VEGF Trap) in Advanced Ovarian Cancer Patients With Recurrent Symptomatic Malignant Ascites | July 2006 | October 2009 |
| NCT00358878 | Completed | Phase 3 | Cirrhotic Ascites Treatment With Satavaptan in Patients With Ascites Due to Cirrhosis of the Liver (CATS) | July 2006 | December 2008 |
| NCT01030185 | Completed | Phase 2/Phase 3 | Safety and Performance of the Automated Fluid Shunt in Patients With Ascites and Diuretic Resistance | February 2010 | June 2013 |
| NCT00006166 | Completed | Phase 3 | North American Study for the Treatment of Refractory Ascites (NASTRA) | March 1997 | October 2001 |
| NCT00490217 | Completed | Spontaneous Bacterial Peritonitis: Incidence, Risk Factors and Outcome | December 1993 | March 2007 | |
| NCT00501384 | Completed | Phase 2 | Satavaptan Dose-Ranging Study in the Prevention of Ascites | April 2004 | May 2005 |
| NCT00501566 | Completed | Phase 2 | Satavaptan Dose-Ranging Study in Normonatraemic Patients With Cirrhotic Ascites | April 2004 | January 2005 |
| NCT00501722 | Completed | Phase 2 | Satavaptan Dose-Ranging Study in Hyponatraemic Patients With Cirrhotic Ascites | April 2004 | March 2005 |
| NCT00570622 | Completed | Phase 4 | Effect of Pioglitazone on Portal and Systemic Hemodynamics in Patients With Advanced Cirrhosis | December 2004 | November 2008 |
| NCT00591968 | Completed | N/A | Telesonography Adaptation and Use to Improve the Standard of Patient Care Within a Dominican Community | January 2008 | March 2008 |
| NCT00741663 | Completed | Phase 4 | Spironolactone Versus Spironolactone Plus Furosemide (SVSSF) | April 2005 | September 2008 |
| NCT00825877 | Completed | Long-term Follow-up of HALT-C Sustained Virological Responders | January 15, 2009 | June 29, 2012 | |
| NCT00907673 | Completed | N/A | The Automated Fluid Shunt (AFS)in Chronic Congestive Heart Failure | May 2009 | March 2010 |
| NCT00968695 | Completed | Phase 4 | Effects of Long Term Albumin 20% Administration in Patients With Cirrhosis and Ascites. | July 2009 | April 2014 |
| NCT00005906 | Completed | Phase 2 | Treatment With Octreotide in Patients With Lymphangioleiomyomatosis | June 2000 | |
| NCT01059396 | Completed | Phase 4 | Study on B-blockers to Prevent Decompensation of Cirrhosis With HTPortal | January 28, 2010 | July 15, 2015 |
| NCT01150916 | Completed | N/A | B-type Natriuretic Peptide in the Diagnosis of Heart Failure Related Ascites | June 2010 | March 2012 |
| NCT01188746 | Completed | N/A | Impact of Palliative Catheter Placement on the Quality of Life of Patients With Refractory Ascites | August 2010 | February 2020 |
| NCT01288794 | Completed | Phase 4 | Human Albumin for the Treatment of Ascites in Patients With Hepatic Cirrhosis | March 2011 | May 2016 |
| NCT01292304 | Completed | Phase 4 | Tolvaptan for Ascites in Cirrhotic Patients | March 2012 | January 2015 |
| NCT01349335 | Completed | Phase 2 | Dose Exploring and Setting Study for Tolvaptan to Treat Hepatic Cirrhosis With Ascites | April 2009 | April 2010 |
| NCT01349348 | Completed | Phase 3 | Phase III Study of Tolvaptan Tablet to Treat Cirrhosis Ascites | October 2010 | July 2012 |
| NCT01359462 | Completed | Phase 1 | Multiple-dose Pharmacokinetics Study of Tolvaptan Tablets in Chinese Patients With Hepatocirrhosis | April 2009 | January 2010 |
| NCT01403987 | Completed | N/A | Improving Performance of Paracentesis in Medical Residency Training | January 2011 | March 2012 |
| NCT01578226 | Completed | Procalcitonin in Cirrhotic Patients at High Risk for Sepsis | October 2009 | September 2011 | |
| NCT01769040 | Completed | Phase 4 | Intestinal Decontamination With Rifaximin. The Inflammatory and Circulatory State in Patients With Cirrhosis | November 2012 | January 2016 |
| NCT02400164 | Completed | N/A | A (M)Ulti-center, Prospective, (O)Pen Label, Uncontrolled Feasibility (S)Tudy to Assess the Safety and Effectiveness of an Automatic Low Flow (A)Scites (Alfa) Pump (I)n Patients With (C)Irrhosis and Refractory or Recurrent Ascites | March 2015 | March 31, 2018 |
| NCT02608658 | Completed | N/A | Evaluation of Serum-Derived Bovine Immunoglobulin Protein Isolate in Subjects With Decompensated Cirrhosis With Ascites | March 2016 | April 27, 2017 |
| NCT02638051 | Completed | Phase 2 | Local mEHT + TCM Versus Intraperitoneal Chemoinfusion in Treatment of Malignant Ascites: Phase II RCT | January 2014 | December 2015 |
| NCT02649335 | Completed | Phase 3 | To Study the Effect of Nonselective Beta Blockers in Advanced Stage Liver Disease With Ascites | July 1, 2015 | December 30, 2016 |
| NCT02787772 | Completed | N/A | Abdominal Hernia in Cirrhotic Patients: Surgery or Conservative Treatment? | January 2009 | January 2016 |
| NCT02821377 | Completed | Phase 2 | Metabolic Effects of Furosemide +HSS in Refractory Ascites | December 2013 | April 2016 |
| NCT02975726 | Completed | N/A | Peritoneal Dialysis Catheters for the Treatment of Refractory Ascites | January 2017 | February 2019 |
| NCT03069131 | Completed | Phase 3 | Two Strategies of Primary Prophylaxis of Spontaneous Bacterial Peritonitis in Severe Cirrhotic Patients With Ascites | March 20, 2018 | March 20, 2023 |
| NCT03263598 | Completed | Validation of Diagnostic Usefulness of the Random Urine Na/K Ratio for Replacement of 24hr Urine Na Excretion in Cirrhotic Patients With Ascites | May 2016 | February 2020 | |
| NCT03327688 | Completed | N/A | Point-of-care Ultrasound in Finland | October 20, 2017 | December 31, 2019 |
| NCT03493204 | Completed | N/A | Tackling 30-day Readmissions in Patients With Cirrhosis: The SALTYFOOD Trial | April 24, 2018 | August 19, 2019 |
| NCT04245553 | Completed | N/A | Does Point of Care Ultrasound Change Needle Insertion Location During Routine Bedside Paracentesis? | February 7, 2020 | March 1, 2021 |
| NCT04533854 | Completed | Investigating Signal Change in Malignant and Non-malignant Pleural Effusions and asCitic Fluid Using fTiR Analysis | March 26, 2021 | September 26, 2023 | |
| NCT04641364 | Completed | Phase 1 | Safety and Tolerance Study of Recombinant Human Albumin Injection in Healthy Subjects. | June 24, 2019 | May 6, 2020 |
| NCT04650295 | Completed | N/A | Non-Pharmaceutical Intervention for Cirrhotic Cramps Reduction: The NICCles Trial | January 18, 2021 | December 2, 2021 |
| NCT04675775 | Completed | N/A | The BRAINFOOD Trial to Prevent Recurrent Hepatic Encephalopathy. | January 21, 2021 | March 5, 2023 |
| NCT04701697 | Completed | Phase 1 | Phase Ib of Recombinant Human Albumin Injection | March 15, 2020 | October 25, 2020 |
| NCT05013502 | Completed | Phase 1 | Empagliflozin in Diuretic Refractory Ascites | November 15, 2021 | June 30, 2023 |
| NCT05309200 | Completed | Phase 2 | A Study of OCE-205 in Participants With Cirrhosis With Ascites Who Developed Hepatorenal Syndrome-Acute Kidney Injury | April 28, 2022 | October 13, 2023 |
| NCT05278013 | Enrolling by invitation | N/A | Utility of 2- Octyl Cyanoacrylate (2-OCA) | January 13, 2022 | January 13, 2024 |
| NCT05569798 | Not yet recruiting | N/A | The INSIGHT Feasibility Study Ultrasound in the Intensive Care Unit: A Randomised Controlled Feasibility Trial | December 4, 2023 | December 1, 2024 |
| NCT06436807 | Not yet recruiting | PMCF Study of the CE-marked Drainova® ArgentiC Catheter | May 2024 | August 2026 | |
| NCT05867602 | Recruiting | Phase 2 | High Dose Albumin in Refractory Ascites | March 25, 2019 | March 2026 |
| NCT03506893 | Recruiting | N/A | Medical-economic Evaluation of the Care of Refractory Ascites by Implantation of Alfapump® Device in Cirrhotic Patients | July 17, 2018 | December 31, 2025 |
| NCT04767945 | Recruiting | Cirrhosis Registry of Hospitalized Patients | July 1, 2014 | December 31, 2029 | |
| NCT05900050 | Recruiting | Phase 2 | Efficacy, Safety and Tolerability of VS-01 in Adult Patients With Acute-on-Chronic Liver Failure and Ascites (UNVEIL-IT)™ | July 2, 2023 | June 2025 |
| NCT05511766 | Recruiting | Phase 2/Phase 3 | Allopurinol Versus Atorvastatin to Prevent Complications of Liver Cirrhosis | November 15, 2022 | January 30, 2025 |
| NCT05734729 | Recruiting | N/A | Clinical Validation of Programmable Drain Fluid Regulator to Reduce Morbidity, Care Requirements, and Improve Outcomes | February 27, 2023 | September 2025 |
| NCT05025878 | Recruiting | 13C-Glucose Tracing of Tumour and T Cells in the Ascites of Ovarian Cancer Patients. | October 20, 2021 | August 2023 | |
| NCT03267615 | Recruiting | VICIS - Vienna Cirrhosis Study | February 1, 2017 | December 31, 2027 | |
| NCT05700708 | Recruiting | Point-of-Care Echocardiography to Assess Impact of Dynamic Cardiac Function, Renal and Cardiac Biomarkers in Cirrhosis With Refractory Ascites | November 15, 2022 | July 15, 2024 | |
| NCT02742428 | Suspended | N/A | Preoperative Ascites Drainage Versus Standard Care for Patients With Advanced Ovarian Cancer | January 2018 | March 2020 |
| NCT00511394 | Suspended | N/A | Acute Hemodynamics of Albumin Versus Normal Saline in Cirrhosis | May 2007 | December 2008 |
| NCT01701297 | Terminated | Phase 2 | VSL#3 and Spontaneous Bacterial Peritonitis | February 2012 | October 2014 |
| NCT00796861 | Terminated | Phase 2 | Trial of Sunitinib for Refractory Malignant Ascites | May 2007 | April 2011 |
| NCT00366795 | Terminated | Phase 3 | Satavaptan for the Prevention of Ascites Recurrence in Patients With Ascites Due to Cirrhosis of the Liver | August 2006 | December 2008 |
| NCT01455246 | Terminated | Phase 2/Phase 3 | Daptomycin + Meropenem Versus Ceftazidime in the Treatment of Nosocomial Spontaneous Bacterial Peritonitis | October 2010 | July 2014 |
| NCT03827200 | Terminated | Phase 2 | A Study Evaluating the Utility of Ambrisentan in Lowering Portal Pressure in Patients With Liver Cirrhosis | April 11, 2019 | January 21, 2021 |
| NCT00359437 | Terminated | Phase 3 | Satavaptan in the Prevention of Ascites Recurrence in Patients With Ascites Due to Cirrhosis of the Liver | July 2006 | October 2008 |
| NCT01236339 | Terminated | N/A | Early TIPS for Ascites Study | December 2010 | March 2013 |
| NCT04112199 | Terminated | Phase 2 | A Study for Evaluation of BIV201 to Reduce Ascites and Complications in Patients With Cirrhosis and Refractory Ascites | June 17, 2021 | May 8, 2023 |
| NCT04232384 | Terminated | N/A | Comparison of "Roll-over' Technique With Standard Abdominal Paracentesis in Suspected Peritoneal Carcinomatosis | June 15, 2020 | July 1, 2021 |
| NCT02417753 | Terminated | Phase 2 | AZD9150, a STAT3 Antisense Oligonucleotide, in People With Malignant Ascites | April 3, 2015 | April 7, 2016 |
| NCT00548366 | Terminated | Phase 4 | Sodium Restriction in the Management of Cirrhotic Ascites | October 2007 | September 2010 |
| NCT04550091 | Unknown status | Role Of Multi-detector Computed Tomography In Differentiation Between Different Types Of Ascites | October 19, 2020 | October 2022 | |
| NCT04640116 | Unknown status | N/A | TIPS Combined With Microwave Ablation in HCC Patients With Refractory Ascites | February 1, 2021 | June 30, 2023 |
| NCT02755701 | Unknown status | Phase 4 | The Effect of Branched-chain Amino Acid on the Improvement of Serum Albumin Level in Cirrhotic Patients With Ascites | July 2016 | December 2018 |
| NCT02811406 | Unknown status | N/A | The Role of Intravenous Albumin Replacement During Abdominal Paracentesis in Patients With Malignancy Related Ascites | June 2016 | December 2017 |
| NCT02891642 | Unknown status | Liquid Biopsy With Immunomagnetic Beads Capture Technique for Malignant Cell Detection in Body Fluid | September 2016 | February 2021 | |
| NCT03205748 | Unknown status | Evaluation of Different Etiologies of Obscure Ascites | August 1, 2017 | November 2018 | |
| NCT03210298 | Unknown status | International Registry of Patients Treated With Pressurized IntraPeritoneal Aerosol Chemotherapy (PIPAC) | January 2016 | September 2022 | |
| NCT05220891 | Unknown status | Comparison of Crystalloid and Colloid I.V Fluid Therapy in Prevention of Paracentesis Induced Circulatory Dysfunction (PICD) and Renal Dysfunction in Patients With Decompensated Liver Cirrhosis in Egypt: a Randomized Piolet Study | January 11, 2023 | February 11, 2024 | |
| NCT03341221 | Unknown status | Diagnosis of Ascites in Infants and Children | December 1, 2017 | November 1, 2018 | |
| NCT01073345 | Unknown status | Portal Venous Hemodynamic Changes After Hepatectomy | February 2010 | December 2010 | |
| NCT04279327 | Unknown status | Cell Block Immunohistochemistry in Effusion Cytology | April 1, 2020 | January 2022 | |
| NCT01421550 | Unknown status | Phase 3 | Conservative Treatment Versus Elective Repair of Umbilical Hernia in Patients With Ascites and Liver Cirrhosis | January 2011 | December 2015 |
| NCT00239096 | Unknown status | Phase 4 | Prevention of Decompensation in Liver Cirrhosis | September 2005 | September 2011 |
| NCT01716611 | Unknown status | Phase 4 | Tolvaptan for Hyponatremia in Cirrhotic Patients With Ascites | November 2012 | February 2014 |
| NCT02022150 | Unknown status | Body Composition Analysis in Cirrhotic Undergoing Paracentesis | December 2012 | December 2021 | |
| NCT02120196 | Unknown status | Phase 3 | Comparative Study of Rifaximin Versus Norfloxacin in the Secondary Prophylaxis of Spontaneous Bacterial Peritonitis | January 2014 | December 2023 |
| NCT02895919 | Withdrawn | Bedside Inoculation of Ascitic Fluid in Diagnostic Paracentesis | August 22, 2016 | August 19, 2018 | |
| NCT01331785 | Withdrawn | N/A | Mechanism and the Effect of Midodrine on Portal Pressures in Patients With Cirrhosis | April 2011 | July 2012 |
| NCT00603200 | Withdrawn | Effect of Large Volume Paracentesis on Fatigue in Cirrhosis | January 2008 | December 2009 | |
| NCT01777971 | Withdrawn | The Effect of a Large-volume Paracentesis on Fatigue, Sleep, and Quality of Life in Cirrhosis | July 2012 | October 2014 | |
| NCT01091233 | Withdrawn | The Influence of Paracentesis on Intra-abdominal Pressure and Kidney Function in Critically Ill Patients With Liver Cirrhosis and Ascites: an Observational Study | March 2010 | December 2012 | |
| NCT01801228 | Withdrawn | Phase 2 | Eplerenone Versus Spironolactone as Treatment of Ascites Due to Liver Cirrhosis; a Study of Efficacy and Side Effects | February 2013 | October 2015 |
| NCT00760032 | Withdrawn | Phase 4 | Lipopolysaccharide Binding Protein and Development of Infectious Events in Cirrhotic Patients |
- HPO Human Phenotype ID (Human Phenotype Ontology)
- HP:0001541
- ICD10 preferred id (Insert disease from ICD10)
- D0014993
- ICD10 class code (Insert disease from ICD10)
- R18
- MeSH unique ID (MeSH (Medical Subject Headings))
- D001201